WeinzimmerL.G.BondE.U.HoustonM.B.NystromP.C. (2003) ‘Relating marketing expertise on the top management team and strategic market aggressiveness to financial performance and shareholder value’, Journal of Strategic Marketing11, 133–150.
3.
YeohP-L.RothK. (1999) ‘An empirical analysis of sustained advantage in the us pharmaceutical industry: Impact of firm resources and capabilities’, Strategic Management Journal20, 637–653.
4.
RothaermelF.DeedsD.L. (2004) ‘Exploration and exploitation alliances in biotechnology: A system of new product development’, Strategic Management Journal25, 201–221.
5.
DorseyBleil L.KalamasJ.MathodaR.K. (2004) ‘How to control health benefit costs’, McKinsey Quarterly1, 104–113.
6.
HiningsC.R.CasebeerA.ReayT. (2003) ‘Regionalizing healthcare in Alberta: Legislated change, uncertainty and loose coupling’, British Journal of Management14, S15–S30.
7.
BoltonS.A. (2004) Journal of Management Studies, 41(2), 318–333.
8.
KahnB.LuceM.F. (2003) ‘Understanding high stakes consumer decisions: Mammography adherence following false-alarm test results’, Marketing Science22(3), 393–410.
